Transcriptomics

Dataset Information

0

Gene Expression in Fixed Tissues and Outcome in Hepatocellular Carcinoma


ABSTRACT: Background: It is a challenge to identify those patients who, after undergoing potentially curative treatments for hepatocellular carcinoma, are at greatest risk of recurrence. Such high-risk patients could receive novel interventional measures. An obstacle to the development of genome-based predictors of outcome in patients with hepatocellular carcinoma has been the lack of a means to carry out genomewide expression profiling of fixed, as opposed to frozen, tissues. Methods: We aimed to demonstrate the feasibility of gene-expression profiling of more than 6000 human genes in formalin-fixed paraffin-embedded tissues. We applied the method to tissues from 307 patients with hepatocellular carcinoma, from four series of patients, to discover and validate a gene-expression signature associated with survival. Results: The expression-profiling method for formalin-fixed, paraffin-embedded tissue was highly effective: samples from 90% of the patients yielded data of high quality, including samples that had been archived for more than 24 years. Gene-expression profiles of tumor tissue failed to yield a significant association with survival. In contrast, profiles of the surrounding nontumoral liver tissue were highly correlated with survival in a training set of 82 Japanese patients, and the signature was validated in tissues from an independent group of 225 patients from the United States and Europe (p = 0.04). Conclusions: We have demonstrated the feasibility of genomewide expression profiling of formalin-fixed, paraffin-embedded tissues and have shown that a reproducible gene-expression signature correlating with survival is present in liver tissue adjacent to the tumor in patients with hepatocellular carcinoma. This SuperSeries is composed of the following subset Series: GSE10140: Gene Expression in Fixed Tissues and Outcome in Hepatocellular Carcinoma (Training Set, Liver) GSE10141: Gene Expression in Fixed Tissues and Outcome in Hepatocellular Carcinoma (Training Set, HCC) GSE10142: Gene Expression in Fixed Tissues and Outcome in Hepatocellular Carcinoma (Validation Set) Keywords: Hepatocellular carcinoma, Expression array, Illumina, Signatures, Outcome prediction Training cohort: 80 tumor and 82 non-tumor liver tissues surgically resected from patients with hepatocellular carcinoma (HCC); Validation cohort: 225 non-tumor liver tissues surgically resected from patients with HCC. Clinical data has been withheld from GEO due to privacy concerns.

ORGANISM(S): Homo sapiens  

SUBMITTER: Masashi Hashimoto   Hiromitsu Kumada  Michael Reich  Matthew J Wrobel  Augusto Villanueva  Jordi Bruix  Stacey Gabriel  Masahiro Kobayashi  Yujin Hoshida  Goro Watanabe  Jim Lerner  Jamie Moore  Amy Camargo  Judit Peix  Swan Thung  Todd R Golub  Josep M Llovet  Scott Friedman  Kenji Ikeda  Myron Schwartz  Jennifer A Chan  Supriya Gupta  Vincenzo Mazzaferro  Sasan Roayaie  Derek Chiang 

PROVIDER: E-GEOD-10143 | ArrayExpress | 2010-05-20

SECONDARY ACCESSION(S): GSE10143PRJNA108689

REPOSITORIES: GEO, ArrayExpress

altmetric image

Publications


It is a challenge to identify patients who, after undergoing potentially curative treatment for hepatocellular carcinoma, are at greatest risk for recurrence. Such high-risk patients could receive novel interventional measures. An obstacle to the development of genome-based predictors of outcome in patients with hepatocellular carcinoma has been the lack of a means to carry out genomewide expression profiling of fixed, as opposed to frozen, tissue.We aimed to demonstrate the feasibility of gene-  ...[more]

Similar Datasets

2010-05-18 | E-GEOD-10140 | ArrayExpress
2010-05-19 | E-GEOD-10141 | ArrayExpress
2010-05-19 | E-GEOD-10142 | ArrayExpress
2008-10-15 | GSE10140 | GEO
2008-10-15 | GSE10141 | GEO
2008-10-15 | GSE10142 | GEO
2008-10-15 | GSE10143 | GEO
| PRJNA108985 | ENA
2011-02-17 | E-GEOD-19977 | ArrayExpress
2011-02-17 | GSE19977 | GEO